TME PHARM.CONF.IPO EO-,01TME PHARM.CONF.IPO EO-,01TME PHARM.CONF.IPO EO-,01

TME PHARM.CONF.IPO EO-,01

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪7.10 M‬EUR
‪−6.74 M‬EUR
‪16.93 M‬
Beta (1Y)
1.47

About TME PHARMA

CEO
Aram Andrew Mangasarian
Headquarters
Berlin
Employees (FY)
13
Founded
2015
ISIN
NL0015000YE1
FIGI
BBG00LWHB310
TME Pharma NV is a clinical-stage biopharmaceutical company, which focuses on therapeutics targeting the tumor microenvironment or TME. The firm is active in pioneering the development of a new class of proprietary therapeutics called Spiegelmers. Its pipeline includes NOX-A12 and NOX-E36. The company was founded on January 16, 2015 and is headquartered in Berlin, Germany.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange TME PHARM.CONF.IPO EO-,01 stocks are traded under the ticker 0N6A.
We've gathered analysts' opinions on TME PHARM.CONF.IPO EO-,01 future price: according to them, 0N6A price has a max estimate of 0.61 EUR and a min estimate of 0.61 EUR. Watch 0N6A chart and read a more detailed TME PHARM.CONF.IPO EO-,01 stock forecast: see what analysts think of TME PHARM.CONF.IPO EO-,01 and suggest that you do with its stocks.
0N6A reached its all-time high on Jan 28, 2009 with the price of 78.8620 EUR, and its all-time low was 0.1775 EUR and was reached on Dec 22, 2023. View more price dynamics on 0N6A chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track TME PHARM.CONF.IPO EO-,01 financials in yearly and quarterly reports right on TradingView.
TME PHARM.CONF.IPO EO-,01 is going to release the next earnings report on Oct 24, 2024. Keep track of upcoming events with our Earnings Calendar.
No, 0N6A doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 29, 2024, the company has 13.00 employees. See our rating of the largest employees — is TME PHARM.CONF.IPO EO-,01 on this list?
Like other stocks, 0N6A shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TME PHARM.CONF.IPO EO-,01 stock right from TradingView charts — choose your broker and connect to your account.